Bioengineered Stents Market: Key Insights
The bioengineered stents market is expected to grow due to the surging demand for more effective and less invasive medical devices. The increasing prevalence of cardiovascular disease and coronary heart disease and the growing geriatric population drives the market. Bioengineered stents, with their biocompatible materials, are becoming increasingly popular as a treatment option for blocked or narrowed blood vessels as they mimic the natural structure and function of blood vessels, reducing the risk of restenosis and the need for re-intervention. One of the major opportunities in the bioengineered stents market is the increasing adoption of bioengineered stents in emerging economies. This is due to the growing healthcare infrastructure and the increasing awareness about the benefits of bioengineered stents in these regions. Additionally, the development of advanced bioengineered stents, such as drug-eluting bioengineered stents and bioabsorbable stents, is expected to provide further growth opportunities for the bioengineered stents market.
The future trends in the bioengineered stents market include the increasing focus on personalized medicine and the development of smart stents. This is driven by the need for more accurate and efficient treatment options to meet the patient needs. Additionally, the use of 3D printing technology in producing bioengineered stents is expected to drive bioengineered stents market growth in the future.
Increasing Prevalence of Cardiovascular Disease, Coronary Heart Disease and Increasing Number of Geriatric Population is Driving the Bioengineered Stents Market
Cardiovascular disease is a major health issue worldwide, and coronary heart disease is the major subtype. Coronary heart disease is characterized by the buildup of plaque inside the coronary arteries, which can lead to blocked or narrowed blood vessels. This increases the demand for stenting procedures. As bioengineered stents are designed to mimic blood vessels' natural structure and function, they are becoming increasingly popular as a treatment option for blocked or narrowed blood vessels. The geriatric population is also a significant driver of the bioengineered stents market. As the population ages, the incidence of cardiovascular disease increases, and older adults are more likely to require stenting procedures. Additionally, older adults are more likely to have other health issues that may make them poor candidates for traditional mental stents, such as chronic kidney disease and diabetes. With their biocompatible materials, bioengineered stents are a better option for these patients.
Bioengineered Stents Market: Segmental Overview
The global bioengineered stents market is segmented on the basis of application, product, mode of delivery, material, and end user. On the basis of application, the market is segmented as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm, and others. On the basis of product, the market is segmented as drug-eluting stents, bio absorbable stents, and drug-eluting balloons. On the basis of mode of delivery, the market is bifurcated into balloon-expandable stents and self-expanding stents. On the basis of material type the market is bifurcated into metal-based and polymer-based. On the basis of end user, the market is segmented as hospitals cardiac centers, ambulatory surgical centers, and others.
The drug-eluting stents segment is expected to hold a substantial market share of the bioengineered stents market because drug-eluting stents are coated with drugs designed to prevent the restenosis of the blood vessel after the stenting procedure. These stents are preferred over other types, such as bare metal stents because they have been shown to reduce the risk of restenosis by up to 50%. Drug-eluting stents have been widely adopted in clinical practice and have become the standard for treating coronary artery disease. They are available in different types, such as drug-eluting stents with biodegradable polymers and drug-eluting stents with durable polymers, and they have a good safety profile. They have been proven to be effective in reducing the rate of restenosis. The bioabsorbable stents segment is also expected to grow significantly in the bioengineered stents market. These stents are biodegradable materials that dissolve within a few months after deployment, leaving behind a fully restored blood vessel. They are designed to eliminate the risk of late stent thrombosis and restenosis that can occur with permanent stents.
Bioengineered Stents Market: Competitive Landscape and Key Developments
Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys SA, Meril Life Sciences Pvt. Ltd, Vascular Concepts and L. Gore and Associates are among the key players operating in the bioengineered stents market. These companies have a widespread presence worldwide, which provides lucrative opportunities to serve a large number of customers and expand the bioengineered stents market.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com